British American Tobacco/£BATS

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About British American Tobacco

The second-largest tobacco company by volume, British American Tobacco sold 505 billion cigarettes in 2024. Its leading brands are Dunhill, Kent, Pall Mall, Lucky Strike, and Rothmans in cigarettes. Its ownership of the Camel, Natural American Spirit, and Newport brands are limited to the us. In next-generation products, the company has the Vuse brand in vaping, Glo in heated tobacco, and Velo in modern oral tobacco. The company also owns a 25.5% stake in ITC limited, the largest Indian cigarette company.

Ticker

£BATS

Primary listing

LSE

Industry

Tobacco

Employees

48,989

ISIN

GB0002875804

BATS Metrics

BasicAdvanced
£78B
26.05
£1.36
0.26
£2.37
6.78%

What the Analysts think about BATS

Analyst ratings (Buy, Hold, Sell) for British American Tobacco stock.

Bulls say / Bears say

British American Tobacco's New Categories segment, including products like Vuse and Velo, achieved profitability in 2023, two years ahead of schedule, contributing £398 million to group profit at constant exchange rates. (ainvest.com)
The company announced a £700 million share buyback program for 2024, following the sale of a portion of its stake in India's ITC, signaling confidence in its financial position and commitment to returning value to shareholders. (reuters.com)
BAT's Vuse vapour brand maintained a global market leadership with a 40.3% value share, indicating strong performance in the growing e-cigarette market. (nasdaq.com)
BAT reported a larger-than-expected £27.3 billion impairment on its US cigarette brands, with cigarette volumes falling by 11% in 2023 due to consumers downtrading and the impact of illegal disposable vapes. (ft.com)
The company expects first-half revenues and profits to decline due to decreased cigarette sales and the rise of illegal vapes in the U.S., though it maintains its full-year forecast for low single-digit growth. (reuters.com)
BAT's New Categories division, despite showing growth, is still loss-making and not expected to turn a profit until 2024, raising concerns about the company's ability to offset declines in traditional tobacco sales. (investingreviews.co.uk)
Data summarised monthly by Lightyear AI. Last updated on 6 Jul 2025.

BATS Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

BATS Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £BATS

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

Aug1
British American Tobacco
Dividend·Payment
£0.6006Per share
Oct2
British American Tobacco
Dividend·Ex-dividend
Nov7
British American Tobacco
Dividend·Payment
£0.6006Per share
FAQs